Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization

BACKGROUND: There is paucity of information concerning whether AFP change is a predictor of prognosis for recurrent hepatocellular carcinoma (RHCC) patients after trans-arterial chemoembolization (TACE). METHODS: A total of 177 RHCC patients who received TACE as first-line therapy were retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Chao, Zhang, Xiaoyun, Li, Chuan, Peng, Wei, Wen, Tian-Fu, Yan, Lv-Nan, Yang, Jiayin, Lu, Wusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689634/
https://www.ncbi.nlm.nih.gov/pubmed/29156744
http://dx.doi.org/10.18632/oncotarget.20343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689634/
https://www.ncbi.nlm.nih.gov/pubmed/29156744
http://dx.doi.org/10.18632/oncotarget.20343

Ejemplares similares